Aromatase inhibitor-induced arthralgia: Is vitamin D deficiency responsible?

Maturitas

Volumn 69, Issue 1, 2011, Pages 3-4

  Prieto Alhambra, D ^a,b   Javaid, M K ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aromatase inhibitor (AI); Breast cancer; Hormone receptor; Postmenopausal wome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; AROMATASE INHIBITOR; LETROZOLE; VITAMIN D;

ARTHRALGIA; ARTHRITIS; BREAST CANCER; DRUG WITHDRAWAL; EDITORIAL; HUMAN; POSTMENOPAUSE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; FEMALE; HUMANS; VITAMIN D DEFICIENCY;

EID: 79954629251     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.01.001     Document Type: Editorial

References (5)

1. I. Sestak, J. Cuzick, F. Sapunar, R. Eastell, J.F. Forbes, and A.R. Bianco, et al. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Lancet Oncol 9 9 2008 866 872
2. X. Nogues, S. Servitja, M.J. Pena, D. Prieto-Alhambra, R. Nadal, and L. Mellibovsky, et al. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer Maturitas 2010
3. N.L. Waltman, C.D. Ott, J.J. Twiss, G.J. Gross, and A.M. Lindsey Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy Cancer Nurs 2009
4. Q.J. Khan, P.S. Reddy, B.F. Kimler, P. Sharma, S.E. Baxa, and A.P. O'Dea , et al. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer Breast Cancer Res Treat 119 1 2010 111 118
5. Prieto-Alhambra D, Javaid MK, Servitja S, Arden NK, Martinez-Garcia M, Diez-Perez A, et al. Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res Treat, 2010; Jul 28.